Orbimed Advisors LLC Reata Pharmaceuticals Inc Put Options Transaction History

Orbimed Advisors LLC

  • $4.24 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$74.57 - $217.92 $11.2 Million - $32.7 Million
-150,000 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$71.26 - $95.75 $3.56 Million - $4.79 Million
50,000 Added 50.0%
150,000 $12 Million
Q2 2019

Aug 14, 2019
BUY
$77.72 - $94.35 $7.77 Million - $9.44 Million
100,000 New
100,000 $9.44 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email